 |
||||
|
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, July 19, 2006, 26(29):7597-7606; doi:10.1523/JNEUROSCI.0990-06.2006
Previous Article | Next Article
Neurobiology of Disease
Polyglutamine Proteins at the Pathogenic Threshold Display Neuron-Specific Aggregation in a Pan-Neuronal Caenorhabditis elegans Model
Heather R. Brignull, Finola E. Moore, Stephanie J. Tang, andRichard I. Morimoto Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University Institute for Neuroscience, Rice Institute for Biomedical Research, Northwestern University Evanston, Illinois 60208
Correspondence should be addressed to Dr. Richard I. Morimoto, Northwestern University, Department of Biochemistry, 2145 Sheridan Road, Tech MG90, Evanston, IL 60208. Email: r-morimoto{at}northwestern.edu
The basis of neuron-specific pathogenesis, resulting from the expression of misfolded proteins, is poorly understood and of central importance to an understanding of the cell-type specificity of neurodegenerative disease. In this study, we developed a new model for neuron-specific polyQ pathogenesis in Caenorhabditis elegans by pan-neuronal expression that exhibits polyQ length-dependent aggregation, neurotoxicity, and a pathogenic threshold at a length of 35–40 glutamines. Analysis of specific neurons in C. elegans revealed that only at the threshold length, but not at shorter or longer lengths, polyQ proteins can exist in a soluble state in certain lateral neurons or in an aggregated state in motor neurons of the same animal. These results provide direct experimental evidence that the expression of a single species of a toxic misfolded protein can exhibit a range of neuronal consequences.
Key words: polyglutamine; aggregates; neurotoxicity; C. elegans; FRET; FRAP
Received Oct. 13, 2005; revised June 5, 2006; accepted June 10, 2006.
Correspondence should be addressed to Dr. Richard I. Morimoto, Northwestern University, Department of Biochemistry, 2145 Sheridan Road, Tech MG90, Evanston, IL 60208. Email: r-morimoto{at}northwestern.edu
This article has been cited by other articles:
C. R. Guthrie, G. D. Schellenberg, and B. C. Kraemer
SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans
Hum. Mol. Genet., May 15, 2009; 18(10): 1825 - 1838.
[Abstract] [Full Text] [PDF]
J. L. Marsh, T. Lukacsovich, and L. M. Thompson
Animal Models of Polyglutamine Diseases and Therapeutic Approaches
J. Biol. Chem., March 20, 2009; 284(12): 7431 - 7435.
[Abstract] [Full Text] [PDF]
R. I. Morimoto
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Genes & Dev., June 1, 2008; 22(11): 1427 - 1438.
[Abstract] [Full Text] [PDF]
G. Pratt and M. Rechsteiner
Proteasomes Cleave at Multiple Sites within Polyglutamine Tracts: ACTIVATION BY PA28{gamma}(K188E)
J. Biol. Chem., May 9, 2008; 283(19): 12919 - 12925.
[Abstract] [Full Text] [PDF]
T. Takahashi, S. Kikuchi, S. Katada, Y. Nagai, M. Nishizawa, and O. Onodera
Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic
Hum. Mol. Genet., February 1, 2008; 17(3): 345 - 356.
[Abstract] [Full Text] [PDF]
S. M. Garcia, M. O. Casanueva, M. C. Silva, M. D. Amaral, and R. I. Morimoto
Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells
Genes & Dev., November 15, 2007; 21(22): 3006 - 3016.
[Abstract] [Full Text] [PDF]
Y. Wu, Z. Wu, P. Butko, Y. Christen, M. P. Lambert, W. L. Klein, C. D. Link, and Y. Luo
Amyloid-{beta}-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans
J. Neurosci., December 13, 2006; 26(50): 13102 - 13113.
[Abstract] [Full Text] [PDF]
S. Finkbeiner, A. Maria Cuervo, R. I. Morimoto, and P. J. Muchowski
Disease-Modifying Pathways in Neurodegeneration
J. Neurosci., October 11, 2006; 26(41): 10349 - 10357.
[Full Text] [PDF]
|
|
|
|
 |
|